VIII Symposium "Design, Obtaining and Development of Drugs" "SICF"

VIII International Symposium on Chemistry and Pharmaceutical Sciences

SICF

VIII Symposium "Design, Obtaining and Development of Drugs"

interleucina 2 (il-2) × pegylation ×

Book your talks

Plan your experience by adding your favorites talks to your wishlist

Tuesday 14
November 2023

PEGylation strategy for improving the antitumoral activity of the IL-2 mutant no alpha.
Marianniz Díaz Hernández

actividad antitumoral antitumor activity interleucina 2 (il-2) interleukin 2 (il-2) pegilación pegylation polietilenglicol (peg) polyethylene glycol (peg)

PEGylation strategy for improving the pharmacokinetic activity of the IL-2 no-alpha mutein.
Marianniz Díaz Hernández

actividad antitumoral. antitumor activity. farmacocinética interleukin-2 (il-2) mutant mutante de interleucina-2 (il-2) pegilación pegylation pharmacokinetic

Instituto Finlay de Vaunas

EAA Heriberto Duquesne

Gold

Álamo Empresa Cárnica

Silver

BIOCUBAFARMA

Centro de Análisis del Ciclo de Vida (CADIS)